Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04369404 · ClinicalTrials.gov registry record · NA

Impact of Decision Aids in Urogynecology

A NA study, sponsored by Massachusetts General Hospital.

Completed
Registry status
NA
Development phase
66
Enrollment target

NCT04369404: Completed NA study, sponsored by Massachusetts General Hospital.

NCT04369404 is a NA study that has completed, run by Massachusetts General Hospital. The registered enrollment target is 66 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (95% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist → Add completion date to calendar (.ics) →

The verdict

NCT04369404, a NA study, has completed, sponsored by Massachusetts General Hospital.

COMPLETED
Registry status
NA
Development phase
66 participants
Enrollment target

Study Summary

To evaluate how patient knowledge and confidence in decision making can be impacted by shared decision making in common urogynecology conditions.

Primary Outcome

Patients completed four multiple choice knowledge items for each condition and a total knowledge score (0-4) was calculated. The score was converted to a 0-100% scale, with higher scores indicating higher knowledge.

Interventions

  • BEHAVIORAL Pelvic organ prolapse decision aid
  • BEHAVIORAL Stress urinary incontinence decision aid
  • BEHAVIORAL Overactive bladder decision aid

Trial Details

FieldValue
Enrollment Target 66 participants
Start Date 2019-02-01
Est. Completion 2019-06-01
Phase NA
Massachusetts General Hospital

2,032 total trials

What the finished NCT04369404 record still lists

NCT04369404 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 66 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (95% lower).

The record links to 0 conditions, and to 3 interventions - of which Pelvic organ prolapse decision aid is the first listed.

NCT04369404 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT04369404 about?

NCT04369404 is a clinical study titled "Impact of Decision Aids in Urogynecology". To evaluate how patient knowledge and confidence in decision making can be impacted by shared decision making in common urogynecology conditions.

What is the current status of trial NCT04369404?

This trial is currently completed. It is a NA study. The enrollment target is 66 participants. The study started on 2019-02-01. Estimated completion is 2019-06-01.

What interventions are being tested in trial NCT04369404?

The interventions under investigation include: Pelvic organ prolapse decision aid (BEHAVIORAL), Stress urinary incontinence decision aid (BEHAVIORAL), Overactive bladder decision aid (BEHAVIORAL).

Who is sponsoring clinical trial NCT04369404?

This trial is sponsored by Massachusetts General Hospital, which has 2,032 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT04369404's enrollment target sits among peer trials

66 1139th of 2000 higher than 857 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02584244 · 66 participants · Phase 1

    Feasibility of the LUM Imaging System for Detection of Gastrointestinal Cancers

  • NCT03067051 · 66 participants · Phase 1

    Clinical Study to Assess the Safety and Efficacy of the SpectraCure P18 System

  • NCT03754725 · 66 participants · Phase 1

    Ferritin and Iron Burden in SAH sIRB

  • NCT03875378 · 66 participants · Phase 2

    Transdermal Estrogen in Women With Anorexia Nervosa

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT04369404, the US trial registry maintained by the National Library of Medicine. NCT04369404 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.